Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes
Rybelsus from Novo Nordisk is officially the first oral GLP-1 drug approved for this indication. The FDA's decision was based on the SOUL trial, which included data from more than 9,000 patients with type 2 diabetes.
PET holds promise for carotid plaque assessments
PET has already gained significant momentum in recent years. Now, researchers are pointing to another possible use for the popular imaging modality: assessing carotid artery atherosclerosis.
New-onset AFib is common after CABG—but typically not persistent or symptomatic
The study's authors questioned if these patients should even be given oral anticoagulation as currently recommended.
Hospital in Mexico earns first heart failure certification of its kind
A facility outside the United States has received the American Heart Association's Comprehensive Heart Failure Center Certification for the first time.
Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM
No medications are currently approved for the treatment of nonobstructive hypertrophic cardiomyopathy. Could a new drug from Imbria Pharmaceuticals be the first?

Balloon valvuloplasty months after implantation is a safe and effective treatment option for patients with transcatheter heart valve (THV) dysfunction, according to a new analysis published in the Journal of the American College of Cardiology

Late balloon valvuloplasty safe and effective for patients with THV dysfunction

The median time from heart valve implantation to balloon dilatation was 4.6 months.

Lung abnormalities completely resolve for majority of COVID pneumonia patients

A study published this week in Radiology found that 12 months after hospitalization for COVID pneumonia, 93% of patients’ lung abnormalities had cleared up on follow-up chest CT scans.

When PPE is not enough: Improved shielding during EVAR linked to ‘dramatic reduction’ in radiation exposure

“Improving ancillary shielding barriers is paramount,” according to the authors of a brand new analysis.

TAVR Medtronic Evolut EXPAND TAVR II Pivotal Trial,

Is TAVR a sensible choice for patients with moderate, symptomatic aortic stenosis? Medtronic aims to find out

The trial is expected to enroll up to 650 patients from as many as 100 different facilities throughout the world.

Engineers have developed and tested a new wearable device capable of monitoring a person’s blood sugar, alcohol and lactate levels all at the same time, detailing their work in Nature Biomedical Engineering

Small wearable device monitors blood sugar, alcohol and lactate levels at the same time

Engineers detailed their prototype, which is roughly the size of a small stack of quarters, in Nature Biomedical Engineering.

Flu shots lower CVD risk, new meta-analysis confirms

The study's authors tracked data from six different randomized controlled trials, including a large study from 2021 that focused on myocardial infarction patients.

Kaiser Permanente reports nearly $1B loss over COVID surge

California-based health system Kaiser Permanente was slammed by a surge in COVID-19 cases during the first quarter of 2022, playing a role in a nearly $1 billion loss in the first three months of the year.

How did the pig heart transplant patient die? A preventable infection may be to blame

The genetically modified pig heart appears to have been infected with a porcine virus, according to the surgeon who performed the initial transplant.

Clinical

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes

PET holds promise for carotid plaque assessments

New-onset AFib is common after CABG—but typically not persistent or symptomatic

Hospital in Mexico earns first heart failure certification of its kind

Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM